It saddens me to have to report that Panbanisha, the bonobo who understood more about humans than any other nonhuman – and more than most humans – died November 6, 2012, from respiratory illness. Meeting her made it obvious to me that the world is more-than-human and that we have to rethink the inherited cosmology. Pär […]
Continue readingPage 45 of 50
We tend to view logical laws and ethical principles as foundational: as more basic than ordinary discourse, and “making possible” logical and ethical reasoning. They set us on the right intellectual path, so to speak, on the most fundamental level. I want to suggest another possibility: logical laws and ethical principles are derived from ordinary […]
Continue readingThe Centre for Research Ethics and Bioethics (CRB) is currently recruiting two researchers. We are looking for creative persons who like multi-disciplinary collaboration and are fluent in English. 1. Researcher in health economics (UFV-PA 2012/2684): We are looking for a person with a doctoral degree in health economics with documented skills in Discrete Choice Experiments. […]
Continue readingI read Arthur Caplan’s criticism of the personalized gene tests that some companies insist we must buy to gain control over our future health. I could not help wondering if his criticism is applicable also to the idea that biobanks should inform research participants about incidental findings about their genes. Caplan rejects the crystal ball […]
Continue readingI wrote a while ago about drug companies as whistle blowers. Evidently, the pharmaceutical industry wastes more and more resources unsuccessfully trying to replicate published research studies. The amount of irreproducible published research surprised me. If there is such a trend, questions accumulate. Are researchers becoming increasingly careless, or even fraudulent? Are researchers acting under too […]
Continue readingLast week I wrote about the significance of negative results in science. This week I saw one of the saddest documentaries I’ve ever seen, featuring the tragic context of an often cited negative result in science. The documentary, Project Nim (2011), was about the psychologist Herb Terrace’s attempt in the 1970:s to teach American sign […]
Continue readingSome years ago, John Ioannidis warned that most published research findings probably are false. More recently, the drug companies Bayer and Amgen reported that their attempts to replicate scientifically published studies that could be a basis for new drug development most often fail. Amgen, for example, failed to replicate 47 of 53 oncology and hematology […]
Continue readingLast week I participated in HandsOn: Biobanks, an interactive conference exploring the values of biobanking. The warm and collaborative atmosphere made the conference a both moving and encouraging experience. Here is how the conference made me think about the value of biobanks: New techniques of fundamental importance to humanity tend to appear in proportion to […]
Continue readingCollecting biological samples and health information from healthy donors in the construction of biobanks and research registers obviously requires the donors’ informed consent. But is a similar demand for consent reasonable when patients provide their doctor with samples for diagnosis, undergo medical examination and treatment, and answer the doctor’s questions? Or can patients be expected […]
Continue readingIn response to an informative article on personalized medicine and biobanking in Nature Biotechnology, a recent letter to the Editor defends broad consent for biobanking. The three letter writers emphasize the patient and donor perspective: “…patient donors actually express concern that study-specific consent can be burdensome and impede research.” Given these donors’ desire to give so-called broad […]
Continue reading